AURA
Aura Biosciences Inc
NASDAQ: AURA · HEALTHCARE · BIOTECHNOLOGY
$6.30
-1.64% today
Updated 2026-10-29
Market cap
$632.60M
P/E ratio
—
P/S ratio
—
EPS (TTM)
$-1.75
Dividend yield
—
52W range
$5 – $10
Volume
0.9M
Aura Biosciences Inc (AURA) Insider transactions
Net insider activity
Net buying (663,603 shares)
Buy transactions
66
Sell transactions
34
All transactions
| Date | Insider | Title | Type | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 2026-09-01 | PERSON, JULIE | Chief People Officer | Buy | 212,389 | — | — |
| 2026-09-01 | PERSON, JULIE | Chief People Officer | Buy | 107,611 | — | — |
| 2026-09-01 | KRATZ, ERICA | Chief Reg. & Quality Officer | Buy | 199,115 | — | — |
| 2026-09-01 | KRATZ, ERICA | Chief Reg. & Quality Officer | Buy | 100,885 | — | — |
| 2026-09-01 | HOPKINS, JANET JILL | Chief Medical Officer | Buy | 116,150 | — | — |
| 2026-09-01 | HOPKINS, JANET JILL | Chief Medical Officer | Buy | 58,850 | — | — |
| 2026-09-01 | ELAZZOUZI, AMY | SVP, Finance & PAO | Buy | 46,460 | — | — |
| 2026-09-01 | ELAZZOUZI, AMY | SVP, Finance & PAO | Buy | 23,540 | — | — |
| 2026-09-01 | ABU-ABSI, SUSAN | Chief Operating Officer | Buy | 265,487 | — | — |
| 2026-09-01 | ABU-ABSI, SUSAN | Chief Operating Officer | Buy | 134,513 | — | — |
| 2026-07-07 | BENDER, JEREMY | Director | Buy | 60,000 | — | — |
| 2026-07-07 | BENDER, JEREMY | Director | Buy | 30,000 | — | — |
| 2026-07-01 | KILROY, CONOR | See Remarks | Buy | 14,858 | — | — |
| 2026-06-16 | GIBNEY, ANTHONY S | See Remarks | Sale | 12,824 | $6.42 | $82330.08 |
| 2026-06-11 | SRIVASTAVA, SAPNA | Director | Buy | 30,000 | — | — |
| 2026-06-11 | SRIVASTAVA, SAPNA | Director | Buy | 15,000 | — | — |
| 2026-06-11 | MATTESSICH, ANTONY C. | Director | Buy | 30,000 | — | — |
| 2026-06-11 | MATTESSICH, ANTONY C. | Director | Buy | 15,000 | — | — |
| 2026-06-11 | JOHNSON, DAVID MICHAEL | Director | Buy | 30,000 | — | — |
| 2026-06-11 | JOHNSON, DAVID MICHAEL | Director | Buy | 15,000 | — | — |
| 2026-06-11 | BITETTI, TERESA MARIE | Director | Buy | 30,000 | — | — |
| 2026-06-11 | BITETTI, TERESA MARIE | Director | Buy | 15,000 | — | — |
| 2026-05-19 | HOLLES, NATALIE C. | Director, See Remarks | Buy | 2,169,103 | — | — |
| 2026-05-19 | HOLLES, NATALIE C. | Director, See Remarks | Buy | 600,118 | — | — |
| 2026-05-19 | HOLLES, NATALIE C. | Director, See Remarks | Buy | 553,844 | — | — |
| 2026-05-07 | MATRIX, CAPITAL MANAGEMENT COMPANY, LP | 10% Owner | Sale | 6,922,870 | $5.64 | $39.04M |
| 2026-04-16 | KILROY, CONOR | See Remarks | Sale | 11,738 | $7.02 | $82400.76 |
| 2026-03-02 | PLAVSIC, MARK | Chief Technology Officer | Buy | 112,661 | — | — |
| 2026-03-02 | PLAVSIC, MARK | Chief Technology Officer | Buy | 62,339 | — | — |
| 2026-03-02 | KILROY, CONOR | See Remarks | Buy | 112,661 | — | — |
| 2026-03-02 | KILROY, CONOR | See Remarks | Buy | 62,339 | — | — |
| 2026-03-02 | HOPKINS, JANET JILL | Chief Medical Officer | Buy | 160,944 | — | — |
| 2026-03-02 | HOPKINS, JANET JILL | Chief Medical Officer | Buy | 89,056 | — | — |
| 2026-03-02 | GIBNEY, ANTHONY S | See Remarks | Buy | 128,755 | — | — |
| 2026-03-02 | GIBNEY, ANTHONY S | See Remarks | Buy | 71,245 | — | — |
| 2026-03-02 | ELAZZOUZI, AMY | Senior Vice President, Finance | Buy | 80,472 | — | — |
| 2026-03-02 | ELAZZOUZI, AMY | Senior Vice President, Finance | Buy | 44,528 | — | — |
| 2026-03-02 | DE, LOS PINOS ELISABET | Director, See Remarks | Buy | 249,000 | — | — |
| 2026-03-02 | DE, LOS PINOS ELISABET | Director, See Remarks | Buy | 166,000 | — | — |
| 2026-02-17 | PLAVSIC, MARK | Chief Technology Officer | Sale | 15,890 | $5.05 | $80244.50 |
| 2026-02-17 | KILROY, CONOR | See Remarks | Sale | 12,079 | $5.05 | $60998.95 |
| 2026-02-17 | HOPKINS, JANET JILL | Chief Medical Officer | Sale | 20,401 | $5.06 | $103229.06 |
| 2026-02-17 | ELAZZOUZI, AMY | Senior Vice President, Finance | Sale | 8,549 | $5.06 | $43257.94 |
| 2026-02-17 | DE, LOS PINOS ELISABET | Director, See Remarks | Sale | 47,648 | $5.06 | $241098.88 |
| 2026-01-20 | ELAZZOUZI, AMY | Senior Vice President, Finance | Sale | 1,581 | $4.86 | $7683.66 |
| 2026-01-20 | DE, LOS PINOS ELISABET | Director, See Remarks | Sale | 16,928 | $4.86 | $82270.08 |
| 2025-11-17 | HOPKINS, JANET JILL | Chief Medical Officer | Sale | 17,109 | $5.42 | $92730.78 |
| 2025-10-29 | ELAZZOUZI, AMY | Senior Vice President, Finance | Sale | 896 | $6.35 | $5689.60 |
| 2025-10-29 | DE, LOS PINOS ELISABET | Director, See Remarks | Sale | 9,049 | $6.35 | $57461.15 |
| 2025-10-16 | PLAVSIC, MARK | Chief Technology Officer | Sale | 12,169 | $6.35 | $77273.15 |
| 2025-08-18 | ELAZZOUZI, AMY | Senior Vice President, Finance | Sale | 4,744 | — | — |
| 2025-08-18 | ELAZZOUZI, AMY | Senior Vice President, Finance | Sale | 2,554 | — | — |
| 2025-08-18 | ELAZZOUZI, AMY | Senior Vice President, Finance | Sale | 2,319 | — | — |
| 2025-08-18 | ELAZZOUZI, AMY | Senior Vice President, Finance | Sale | 1,094 | — | — |
| 2025-08-18 | ELAZZOUZI, AMY | Senior Vice President, Finance | Sale | 547 | — | — |
| 2025-08-18 | ELAZZOUZI, AMY | Senior Vice President, Finance | Sale | 7,722 | $6.70 | $51737.40 |
| 2025-08-18 | ELAZZOUZI, AMY | Senior Vice President, Finance | Buy | 4,744 | $2.74 | $12998.56 |
| 2025-08-18 | ELAZZOUZI, AMY | Senior Vice President, Finance | Buy | 2,554 | $5.07 | $12948.78 |
| 2025-08-18 | ELAZZOUZI, AMY | Senior Vice President, Finance | Buy | 2,319 | $4.25 | $9855.75 |
| 2025-08-18 | ELAZZOUZI, AMY | Senior Vice President, Finance | Buy | 1,094 | $5.48 | $5995.12 |
| 2025-08-18 | ELAZZOUZI, AMY | Senior Vice President, Finance | Buy | 547 | $5.48 | $2997.56 |
| 2025-06-17 | SRIVASTAVA, SAPNA | Director | Buy | 17,000 | — | — |
| 2025-06-17 | SRIVASTAVA, SAPNA | Director | Buy | 13,000 | — | — |
| 2025-06-17 | MATTESSICH, ANTONY C. | Director | Buy | 17,000 | — | — |
| 2025-06-17 | MATTESSICH, ANTONY C. | Director | Buy | 13,000 | — | — |
| 2025-06-17 | JOHNSON, DAVID MICHAEL | Director | Buy | 17,000 | — | — |
| 2025-06-17 | JOHNSON, DAVID MICHAEL | Director | Buy | 13,000 | — | — |
| 2025-06-02 | GIBNEY, ANTHONY S | See Remarks | Buy | 250,000 | — | — |
| 2025-06-02 | GIBNEY, ANTHONY S | See Remarks | Buy | 150,000 | — | — |
| 2025-06-02 | DE, LOS PINOS ELISABET | Director, See Remarks | Sale | 10,948 | — | — |
| 2025-06-02 | DE, LOS PINOS ELISABET | Director, See Remarks | Buy | 10,948 | $5.07 | $55506.36 |
| 2025-06-02 | DE, LOS PINOS ELISABET | Director, See Remarks | Sale | 9,948 | $6.16 | $61279.68 |
| 2025-05-16 | JOHNSON, DAVID MICHAEL | Director | Buy | 5,000 | — | — |
| 2025-05-16 | JOHNSON, DAVID MICHAEL | Director | Buy | 20,000 | $4.90 | $98000.00 |
| 2025-05-16 | GIBNEY, ANTHONY S | See Remarks | Buy | 12,500 | — | — |
| 2025-05-16 | GIBNEY, ANTHONY S | See Remarks | Buy | 50,000 | $4.90 | $245000.00 |
| 2025-05-16 | GIBNEY, ANTHONY S | See Remarks | Sale | 1,519 | $5.15 | $7822.85 |
| 2025-04-16 | KILROY, CONOR | See Remarks | Sale | 7,162 | $5.49 | $39319.38 |
| 2025-04-16 | ELAZZOUZI, AMY | Senior Vice President, Finance | Sale | 897 | $5.49 | $4924.53 |
| 2025-03-31 | BITETTI, TERESA MARIE | Director | Buy | 29,000 | — | — |
| 2025-03-31 | BITETTI, TERESA MARIE | Director | Buy | 21,000 | — | — |
| 2025-02-18 | PLAVSIC, MARK | Chief Technology Officer | Sale | 2,151 | $7.75 | $16670.25 |
| 2025-02-18 | HOPKINS, JANET JILL | Chief Medical Officer | Sale | 2,534 | $7.75 | $19638.50 |
| 2025-02-18 | ELAZZOUZI, AMY | Senior Vice President, Finance | Sale | 1,404 | $7.75 | $10881.00 |
| 2025-02-18 | DE, LOS PINOS ELISABET | Director, See Remarks | Sale | 20,221 | $7.75 | $156795.66 |
| 2025-02-03 | PLAVSIC, MARK | Chief Technology Officer | Buy | 59,525 | — | — |
| 2025-02-03 | PLAVSIC, MARK | Chief Technology Officer | Buy | 90,475 | — | — |
| 2025-02-03 | KILROY, CONOR | See Remarks | Buy | 59,525 | — | — |
| 2025-02-03 | KILROY, CONOR | See Remarks | Buy | 90,475 | — | — |
| 2025-02-03 | HOPKINS, JANET JILL | Chief Medical Officer | Buy | 79,365 | — | — |
| 2025-02-03 | HOPKINS, JANET JILL | Chief Medical Officer | Buy | 120,635 | — | — |
| 2025-02-03 | ELAZZOUZI, AMY | Senior Vice President, Finance | Buy | 29,760 | — | — |
| 2025-02-03 | ELAZZOUZI, AMY | Senior Vice President, Finance | Buy | 45,240 | — | — |
| 2025-02-03 | DE, LOS PINOS ELISABET | Director, See Remarks | Buy | 255,680 | — | — |
| 2025-02-03 | DE, LOS PINOS ELISABET | Director, See Remarks | Buy | 194,320 | — | — |
| 2025-01-21 | ELAZZOUZI, AMY | Vice President, Finance | Sale | 1,001 | $7.67 | $7679.17 |
| 2025-01-21 | DE, LOS PINOS ELISABET | Director, See Remarks | Sale | 15,955 | $7.67 | $122381.23 |
| 2024-11-18 | HOPKINS, JANET JILL | Chief Medical Officer | Sale | 11,822 | $9.36 | $110663.38 |
| 2024-10-29 | ELAZZOUZI, AMY | Vice President, Finance | Sale | 553 | $10.74 | $5938.39 |
| 2024-10-29 | DE, LOS PINOS ELISABET | Director, See Remarks | Sale | 9,200 | $10.74 | $98787.76 |
Frequently asked questions
Are AURA insiders buying or selling?
Over the transactions on record, AURA insiders have been net buyers, with about $40.78M in stock sold across 34 sales, against 8 open-market purchases.
Does insider selling at AURA mean the stock will fall?
Not by itself. Most executive selling is pre-scheduled through 10b5-1 plans filed months in advance, and insiders sell for diversification, taxes, and liquidity far more often than out of any view on the price. Insider buying is the stronger signal, especially when several insiders buy around the same time, because there is usually only one reason to put personal cash into the stock.
Which AURA insiders are selling the most?
Recent selling is concentrated in a few names. MATRIX, CAPITAL MANAGEMENT COMPANY, LP accounts for the largest share on record, with about $39.04M sold. Selling by one or two individuals matters less than broad selling across the whole leadership team, which is the pattern worth watching.